The Zurich Heart House creates and communicates new knowledge in the field of cardiovascular diseases. Through its affiliation with the University of Zurich, the editorial mandate of the “European Heart Journal” and as the seat of the “Foundation for Cardiovascular Research”, the Zurich Heart House is one of the most important cardiology research and education centres in Europe.
This editorial refers to ‘Association of circulating fatty acids with cardiovascular disease risk: analysis of individual-level data in three large prospec
Work-related stress associated with adverse cardiovascular health in diverse US adult population, indicating potential risk factor for CVD prevention.
Join your community from 7-9 February and access an extensive Course Programme diving into cutting-edge valvular science and practice. Engage with peers and renowned professionals…
Podcast Episode · Pediheart: Pediatric Cardiology Today · 11/08/2024 · 30m
WASHINGTON — A bioadaptor implant adaptable to vessel physiology was linked to fewer target lesion failure events after 6 months compared with a drug-eluting stent,…
European and American perspectives, November 8, 2024
Different from other high cardiovascular (CV) risks populations, the evidence supporting the CV protective effect of LDL-C reduction with statins in chronic kidney disease (CKD)…
🙏सुंदर कांड दोहा २८ (अर्थ सहित)🙏जय बजरंग बली🙏जय श्रीराम
The availability of cardiac myosin inhibitors (CMI) to treat symptomatic left ventricular outflow tract obstruction (LVOTO) and the evolving recommendation
AbstractBackground and Aims. The optimal revascularization strategy in patients with ischaemic cardiomyopathy remains unclear with no contemporary randomiz
